These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 5864379)

  • 21. [Triethylene melamine: new chemotherapeutic agent for tumors].
    ROETTEGLIA E
    Minerva Farm; 1953 May; 2(5):177. PubMed ID: 13086708
    [No Abstract]   [Full Text] [Related]  

  • 22. Understand the benefits and risks of intraperitoneal therapy for advanced ovarian cancer.
    Oestreicher P
    ONS Connect; 2007 Apr; 22(4):24-5. PubMed ID: 17477008
    [No Abstract]   [Full Text] [Related]  

  • 23. [Early resistance to triethylene melamine].
    LATTANZI A; PARDELLI G
    Riforma Med; 1954 Jan; 68(1):7-12. PubMed ID: 13156339
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinical contribution to the treatment of various types of hemoblastosis with triethylene melamine].
    CATTANEO O
    G Ital Chemioter; 1954; 1(3-4):557-8. PubMed ID: 14391668
    [No Abstract]   [Full Text] [Related]  

  • 25. [Triethylene melamine therapy of leukemia and lymphogranulomatosis].
    MILIC N
    Lijec Vjesn; 1954; 76(1-2):40-6. PubMed ID: 13175578
    [No Abstract]   [Full Text] [Related]  

  • 26. Triethylene melamine (TEM) therapy in malignant diseases.
    RUNDLES RW
    GP; 1954 May; 9(5):75-80. PubMed ID: 13151309
    [No Abstract]   [Full Text] [Related]  

  • 27. [Protein concentration in the cells of rat ovary ascitic tumor (strain OIa)].
    Arkhipova LD; Efimov ML; Zhumaletdinov F
    Vopr Onkol; 1969; 15(3):74-7. PubMed ID: 5406694
    [No Abstract]   [Full Text] [Related]  

  • 28. Triethylene melamine in clinical cancer chemotherapy.
    GELLHORN A; KLIGERMAN MM; JAFFE I
    Am J Med; 1952 Oct; 13(4):428-31. PubMed ID: 12985600
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effects of x-ray and triethylene melamine in a case of lymphogranulomatosis].
    VOSS C
    Dtsch Med J; 1955 Feb; 6(3-4):103-5. PubMed ID: 14365476
    [No Abstract]   [Full Text] [Related]  

  • 30. Intraperitoneal administration of Taxol in the management of ovarian cancer.
    Markman M; Rowinsky E; Hakes T; Reichman B; Jones W; Lewis JL; Rubin S; Curtin J; Barakat R; Almadrones L
    J Natl Cancer Inst Monogr; 1993; (15):103-6. PubMed ID: 7912515
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cytotoxic drugs and malignant tumors; action of triethylene melamine, of diethylene-dipropryloxy-benzoquinone and of thiophosphoramide].
    RAVINA A; PESTEL M
    Presse Med (1893); 1958 Mar; 66(17):371-4. PubMed ID: 13542572
    [No Abstract]   [Full Text] [Related]  

  • 32. [Clinical experiences with triethylene melamine in therapy of neoplastic diseases of the blood].
    BOCK HE; KIRBERGER E; WOELFFER U
    Z Klin Med; 1953; 150(5):482-98. PubMed ID: 13137291
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clinical trials with triethylene melamine].
    FERRARI M; KASDORF H
    Arch Urug Med Cir Espec; 1953; 42(3-4):134-44. PubMed ID: 14350952
    [No Abstract]   [Full Text] [Related]  

  • 34. [30 Cases of hemoblastosis and 6 cases of neoplasms of various types treated with triethylenemelamine].
    STORTI E; MANZINI E
    G Ital Chemioter; 1954; 1(1):116-9. PubMed ID: 13191601
    [No Abstract]   [Full Text] [Related]  

  • 35. [A study of the cell cycle in the rat transplantable ascitic tumor (strain OIa)].
    Barkan RS; Levin VL
    Tsitologiia; 1966; 8(5):615-21. PubMed ID: 5974625
    [No Abstract]   [Full Text] [Related]  

  • 36. [Pharmacokinetics study of intraperitoneal cisplatin in ovarian carcinoma].
    Han GR; Cai GF
    Zhonghua Fu Chan Ke Za Zhi; 1993 Apr; 28(4):224-6, 254. PubMed ID: 8404307
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Triethylene melamine in the treatment of lymphomas and other neoplastic diseases.
    BURTNER OW; JENSEN LC; RUMBALL JM
    Ann Intern Med; 1953 Jun; 38(6):1222-44. PubMed ID: 13065973
    [No Abstract]   [Full Text] [Related]  

  • 38. Further observations on the use of triethylene melamine in neoplastic diseases.
    WRIGHT JC; PRIGOT A; WRIGHT LT; ARONS I
    AMA Arch Intern Med; 1952 Mar; 89(3):387-404. PubMed ID: 14902152
    [No Abstract]   [Full Text] [Related]  

  • 39. Hyperbaric oxygen alone or combined with 5-FU attenuates growth of DMBA-induced rat mammary tumors.
    Stuhr LE; Iversen VV; Straume O; Maehle BO; Reed RK
    Cancer Lett; 2004 Jul; 210(1):35-40. PubMed ID: 15172118
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral triethylene melamine therapy in human neoplastic disease.
    BLACKBURN EK; KING GM
    J Fac Radiol; 1954 Oct; 6(2):96-103. PubMed ID: 24543599
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.